1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow MicuRx: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI) contezolid acefosamil (IV)/contezolid (PO), Linezolid (IV and PO) - Diabetic Foot Infection | Phase 3 | Recruiting | MicuRx | 865 | 2022-05-03 | 2026-10-13 |
Linezolid (1)
Bulgaria (1) · Estonia (1) · Georgia (1) · Italy (1) · Latvia (1) · Poland (1) · Serbia (1) · United States (1)